Jehovah's Witnesses and cardiac surgery: A single institution's experience

Sharon McCartney, Nicole Guinn, Russell Roberson, Bob Broomer, William White, Steven Hill

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Background Based on biblical doctrines, patients of the Jehovah's Witness faith refuse allogeneic blood transfusion. Cardiac surgery carries a high risk of blood transfusion, but has been performed in Jehovah's Witnesses for many years. The literature contains information on the outcomes of this cohort, but does not detail the perioperative care of these patients. This article describes a single institution's experience in perioperative care of Jehovah's Witnesses undergoing cardiac surgery.

Study Design and Methods A chart review of adult Jehovah's Witness patients undergoing cardiac surgery at Duke University between January 2005 and June 2012 was completed. Institutional protocols regarding preoperative erythropoietin (EPO) therapy and intraoperative isovolemic hemodilution are detailed. Patient demographics and use of various blood conservation techniques are described. Hemoglobin (Hb) at various points throughout the perioperative management, hospital length of stay, and mortality are reviewed as indicators of outcome.

Results Forty-five Jehovah's Witness patients underwent cardiac surgery at Duke University Medical Center. Preoperative EPO increased the mean Hb by 1.2 g/dL before surgery. Intraoperative normovolemic hemodilution was used in 37 patients with intraoperative mean nadir Hb of 10.3 g/dL. Antifibrinolytics and desmopressin were commonly used as coagulation adjuncts. Mean cardiopulmonary bypass time was 137 minutes, with mean nadir temperature of 30.5C. The mean length of hospital stay was 6.2 days, with mean intensive care unit stay of 1.7 days. This cohort had zero 90-day mortality in the perioperative period.

Conclusions This case series demonstrates that bloodless cardiac surgery can be performed in select patients refusing allogeneic blood transfusion.

Original languageEnglish (US)
Pages (from-to)2745-2752
Number of pages8
JournalTransfusion
Volume54
Issue number1
DOIs
StatePublished - Oct 1 2014

Fingerprint

Jehovah's Witnesses
Thoracic Surgery
Length of Stay
Blood Transfusion
Perioperative Care
Hemodilution
Hemoglobins
Erythropoietin
Bloodless Medical and Surgical Procedures
Deamino Arginine Vasopressin
Antifibrinolytic Agents
Perioperative Period
Hospital Mortality
Cardiopulmonary Bypass
Intensive Care Units
Demography
Temperature
Mortality

ASJC Scopus subject areas

  • Hematology
  • Immunology
  • Immunology and Allergy
  • Medicine(all)

Cite this

McCartney, S., Guinn, N., Roberson, R., Broomer, B., White, W., & Hill, S. (2014). Jehovah's Witnesses and cardiac surgery: A single institution's experience. Transfusion, 54(1), 2745-2752. https://doi.org/10.1111/trf.12696

Jehovah's Witnesses and cardiac surgery : A single institution's experience. / McCartney, Sharon; Guinn, Nicole; Roberson, Russell; Broomer, Bob; White, William; Hill, Steven.

In: Transfusion, Vol. 54, No. 1, 01.10.2014, p. 2745-2752.

Research output: Contribution to journalArticle

McCartney, S, Guinn, N, Roberson, R, Broomer, B, White, W & Hill, S 2014, 'Jehovah's Witnesses and cardiac surgery: A single institution's experience', Transfusion, vol. 54, no. 1, pp. 2745-2752. https://doi.org/10.1111/trf.12696
McCartney S, Guinn N, Roberson R, Broomer B, White W, Hill S. Jehovah's Witnesses and cardiac surgery: A single institution's experience. Transfusion. 2014 Oct 1;54(1):2745-2752. https://doi.org/10.1111/trf.12696
McCartney, Sharon ; Guinn, Nicole ; Roberson, Russell ; Broomer, Bob ; White, William ; Hill, Steven. / Jehovah's Witnesses and cardiac surgery : A single institution's experience. In: Transfusion. 2014 ; Vol. 54, No. 1. pp. 2745-2752.
@article{501ec30afa7042b39443decfed7f1680,
title = "Jehovah's Witnesses and cardiac surgery: A single institution's experience",
abstract = "Background Based on biblical doctrines, patients of the Jehovah's Witness faith refuse allogeneic blood transfusion. Cardiac surgery carries a high risk of blood transfusion, but has been performed in Jehovah's Witnesses for many years. The literature contains information on the outcomes of this cohort, but does not detail the perioperative care of these patients. This article describes a single institution's experience in perioperative care of Jehovah's Witnesses undergoing cardiac surgery.Study Design and Methods A chart review of adult Jehovah's Witness patients undergoing cardiac surgery at Duke University between January 2005 and June 2012 was completed. Institutional protocols regarding preoperative erythropoietin (EPO) therapy and intraoperative isovolemic hemodilution are detailed. Patient demographics and use of various blood conservation techniques are described. Hemoglobin (Hb) at various points throughout the perioperative management, hospital length of stay, and mortality are reviewed as indicators of outcome.Results Forty-five Jehovah's Witness patients underwent cardiac surgery at Duke University Medical Center. Preoperative EPO increased the mean Hb by 1.2 g/dL before surgery. Intraoperative normovolemic hemodilution was used in 37 patients with intraoperative mean nadir Hb of 10.3 g/dL. Antifibrinolytics and desmopressin were commonly used as coagulation adjuncts. Mean cardiopulmonary bypass time was 137 minutes, with mean nadir temperature of 30.5C. The mean length of hospital stay was 6.2 days, with mean intensive care unit stay of 1.7 days. This cohort had zero 90-day mortality in the perioperative period.Conclusions This case series demonstrates that bloodless cardiac surgery can be performed in select patients refusing allogeneic blood transfusion.",
author = "Sharon McCartney and Nicole Guinn and Russell Roberson and Bob Broomer and William White and Steven Hill",
year = "2014",
month = "10",
day = "1",
doi = "10.1111/trf.12696",
language = "English (US)",
volume = "54",
pages = "2745--2752",
journal = "Transfusion",
issn = "0041-1132",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Jehovah's Witnesses and cardiac surgery

T2 - A single institution's experience

AU - McCartney, Sharon

AU - Guinn, Nicole

AU - Roberson, Russell

AU - Broomer, Bob

AU - White, William

AU - Hill, Steven

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Background Based on biblical doctrines, patients of the Jehovah's Witness faith refuse allogeneic blood transfusion. Cardiac surgery carries a high risk of blood transfusion, but has been performed in Jehovah's Witnesses for many years. The literature contains information on the outcomes of this cohort, but does not detail the perioperative care of these patients. This article describes a single institution's experience in perioperative care of Jehovah's Witnesses undergoing cardiac surgery.Study Design and Methods A chart review of adult Jehovah's Witness patients undergoing cardiac surgery at Duke University between January 2005 and June 2012 was completed. Institutional protocols regarding preoperative erythropoietin (EPO) therapy and intraoperative isovolemic hemodilution are detailed. Patient demographics and use of various blood conservation techniques are described. Hemoglobin (Hb) at various points throughout the perioperative management, hospital length of stay, and mortality are reviewed as indicators of outcome.Results Forty-five Jehovah's Witness patients underwent cardiac surgery at Duke University Medical Center. Preoperative EPO increased the mean Hb by 1.2 g/dL before surgery. Intraoperative normovolemic hemodilution was used in 37 patients with intraoperative mean nadir Hb of 10.3 g/dL. Antifibrinolytics and desmopressin were commonly used as coagulation adjuncts. Mean cardiopulmonary bypass time was 137 minutes, with mean nadir temperature of 30.5C. The mean length of hospital stay was 6.2 days, with mean intensive care unit stay of 1.7 days. This cohort had zero 90-day mortality in the perioperative period.Conclusions This case series demonstrates that bloodless cardiac surgery can be performed in select patients refusing allogeneic blood transfusion.

AB - Background Based on biblical doctrines, patients of the Jehovah's Witness faith refuse allogeneic blood transfusion. Cardiac surgery carries a high risk of blood transfusion, but has been performed in Jehovah's Witnesses for many years. The literature contains information on the outcomes of this cohort, but does not detail the perioperative care of these patients. This article describes a single institution's experience in perioperative care of Jehovah's Witnesses undergoing cardiac surgery.Study Design and Methods A chart review of adult Jehovah's Witness patients undergoing cardiac surgery at Duke University between January 2005 and June 2012 was completed. Institutional protocols regarding preoperative erythropoietin (EPO) therapy and intraoperative isovolemic hemodilution are detailed. Patient demographics and use of various blood conservation techniques are described. Hemoglobin (Hb) at various points throughout the perioperative management, hospital length of stay, and mortality are reviewed as indicators of outcome.Results Forty-five Jehovah's Witness patients underwent cardiac surgery at Duke University Medical Center. Preoperative EPO increased the mean Hb by 1.2 g/dL before surgery. Intraoperative normovolemic hemodilution was used in 37 patients with intraoperative mean nadir Hb of 10.3 g/dL. Antifibrinolytics and desmopressin were commonly used as coagulation adjuncts. Mean cardiopulmonary bypass time was 137 minutes, with mean nadir temperature of 30.5C. The mean length of hospital stay was 6.2 days, with mean intensive care unit stay of 1.7 days. This cohort had zero 90-day mortality in the perioperative period.Conclusions This case series demonstrates that bloodless cardiac surgery can be performed in select patients refusing allogeneic blood transfusion.

UR - http://www.scopus.com/inward/record.url?scp=84908384420&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908384420&partnerID=8YFLogxK

U2 - 10.1111/trf.12696

DO - 10.1111/trf.12696

M3 - Article

C2 - 24809815

AN - SCOPUS:84908384420

VL - 54

SP - 2745

EP - 2752

JO - Transfusion

JF - Transfusion

SN - 0041-1132

IS - 1

ER -